CA
NZ
UK
AU
IND
US
A Form 4 filed on September 3, 2026 disclosed that Shachar Erez, a director of Riskified Ltd. (NASDAQ:RSKD), converted 2,359,974 Class B Ordinary Shares into Class A Ordinary Shares and subsequently sold 100,000 Class A Ordinary Shares on September 2, 2026.
A Form 4 filed with the SEC on September 3, 2026, discloses that Bobak R. Azamian, President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), sold 10,000 shares of common stock on September 2, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed on September 3, 2026 reports that Charles Kane, a director of Symbotic Inc. (NASDAQ:SYM), sold 2,000 shares of Class A Common Stock on September 1, 2026, pursuant to a Rule 10b5-1 trading plan.
Alexander O. Schuth, Chief Financial Officer and Secretary of Denali Therapeutics Inc. (NASDAQ:DNLI), filed a Form 4 on September 3, 2026, disclosing the sale of 2,768 shares of common stock on September 1, 2026.
An amended statement of changes in beneficial ownership for Todd Kahn, CEO and Brand President, Coach at Tapestry, Inc., was filed on September 3, 2026, correcting a stock option figure that had been reported in an original filing dated August 19, 2026.
Josh D. Paul, Chief Accounting Officer of Palo Alto Networks Inc., filed a Form 4 on September 3, 2026, reporting the sale of 900 shares of common stock on September 1, 2026, under a pre-established Rule 10b5-1 trading plan.
An amended ownership statement for Tapestry, Inc. (NYSE:TPR) Chief People Officer Denise Kulikowsky was filed on September 3, 2026, correcting the number of stock options reported in a previously filed statement dated August 19, 2026, with the earliest transaction date of August 17, 2026.
Carlos Nueno, President, International of Teladoc Health, Inc. (NYSE:TDOC), filed a Form 4 on September 3, 2026, disclosing the vesting of restricted stock units and a subsequent sale of common stock on September 1 and 2, 2026.
A Form 4 filed with the SEC on September 3, 2026, discloses that Kevin Hourican, Chair and CEO of Sysco Corp (NYSE:SYY), acquired 84,581 restricted stock units on September 1, 2026, at no cost.
Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc. (NYSE:TDOC), filed a Form 4 on September 3, 2026, reporting share acquisitions from vesting restricted stock units and performance stock units on September 1, 2026, and a sale of shares on September …
Please wait processing your request...